Be a Smart Investor
Sunday, March 8, 2020
Can-Fite (CANF) To Report NASH Study Data In March
Can-Fite BioPharma Ltd. (CANF), which awaits a major catalyst this month, has lost 49 percent of its share price value so far this year.
from RTT - Biotech https://ift.tt/2VWydVG
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment